Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
about
So depression is an inflammatory disease, but where does the inflammation come from?Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileThe Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsIntegrating Interleukin-6 into depression diagnosis and treatmentImmune and Neuroendocrine Mechanisms of Stress Vulnerability and ResilienceInflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant usersDepressive symptoms during rehabilitation period predict poor outcome of lumbar spinal stenosis surgery: a two-year perspective.Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression.Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.Aspirin: a review of its neurobiological properties and therapeutic potential for mental illnessImmunity, aging, and geriatric depressionInflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.The inflammation hypothesis in geriatric depressionThe effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysisFunctional biomarkers of depression: diagnosis, treatment, and pathophysiologyDepression in patients with rheumatoid arthritis: description, causes and mechanisms.The mechanisms by which antidepressants may reduce coronary heart disease riskAssociation of depressive disorders, depression characteristics and antidepressant medication with inflammation.Circulating microRNA-144-5p is associated with depressive disorders.A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot StudyOptimizing the Exercise Prescription for Depression: The Search for Biomarkers of ResponseSomatic drugs for psychiatric diseases: aspirin or simvastatin for depression?Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.The pro-inflammatory profile of depressed patients is (partly) related to obesitySerotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.Treating depression and depression-like behavior with physical activity: an immune perspective.Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depressionTranscriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report.DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEPThe association between immune activation and manic symptoms in patients with a depressive disorder.Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder.A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response.
P2860
Q21245291-7CC1B3A1-4F2A-425D-8D4D-76CF57134F2AQ21245293-2029555D-7287-464A-9D41-4C671D97DA94Q26783012-C266A3A7-20AE-4BB8-AB44-7ACC608B316BQ28070891-31378819-60D9-435A-BBA7-DC38CC49E7BDQ28396103-32BDB9AB-70CF-4AAE-AE51-D253D1B4B44DQ33620656-4408DA9C-BA1E-4296-9CAB-103E2C1E2DD2Q33626044-1AE9FA8B-5045-4457-96A8-07DC90DF9ED4Q33631013-A317C255-0CF7-4ECD-84F7-9E6CF6BE75C7Q34026599-13118459-63A2-4A1B-9109-33A019117E95Q34369407-FA8D68F3-E78F-46D8-97C2-B2E60235A9B4Q34480323-83081130-DD74-463C-9F2A-F01369280426Q34626598-FBE138C8-4D83-4A4A-B3A4-7F9A5D5C3338Q34997238-91CAE546-776F-44F4-9FD4-879F68086B6AQ35023431-5DE304A5-C00C-42D5-8AB4-DDDBB90D43C0Q35046651-EEC9B6AF-758E-430D-B23D-5E7432DCF647Q35177870-834313BE-05AF-4F3C-A69C-D2943D49184BQ35356649-334DE530-F0A8-4071-8FC0-CE5D5129412CQ35356872-00D9B18C-4D95-4E30-9896-D6B8358694DFQ35638534-7867A4F4-C01B-4EA2-8338-EC495AD34ADBQ35731801-B3C1BA0A-1C5B-4728-A34F-C4CE6D5C0DD8Q35844355-4E116C52-BDEE-4F55-A977-BEED3983AC57Q35871861-107E8204-DEF6-4DAF-BFD2-D21582DDD6B2Q35897912-BB4519EA-EA8C-4F50-88D6-95BEE74D742EQ35984653-F97F5486-8F80-49FB-8BAB-68D5ACA12DDEQ36067322-984A558E-6033-4D30-A42F-95CC5A87E6E6Q36438114-94B67DD4-5146-4D42-87CE-2D48EDF392F9Q36524243-7E1E0663-E953-4DA6-AB33-85C4CE833004Q36576591-82901E8F-50C9-465A-A5AF-B1DFB7D6F531Q36583311-86B2D8DA-CDA0-4110-80B6-30DB7AD3F23EQ36889327-C5EB4C4D-006F-4FBC-980B-8DE26A944174Q36905880-0D73B457-E049-45CF-92AE-C5AAA28C4F01Q37032660-6241E352-985B-4CF9-817A-EF65F19EFF22Q37047749-D06CD85A-0359-4F38-A6D3-B3636422258EQ37092101-4F3FA871-FC65-482D-B624-C8C92C259BE6Q37201357-373F8F75-26EB-43CF-A811-43D7A60C1F6BQ37281155-055E63EB-42FB-4135-ABDD-E986771524F4Q37310533-D1643CE9-DE92-4043-BB75-9C04D2B6F231Q37348823-2CCC9289-F5E5-4BC5-A696-C586A6D9BA52Q37395509-F40FC034-A0F3-4E56-8B80-8AF0473667FDQ37453252-4CAD63AF-9BB4-4B3C-A80B-2B577C07CD83
P2860
Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pro-inflammatory cytokines and ...... in major depressive disorder.
@en
Pro-inflammatory cytokines and ...... in major depressive disorder.
@nl
type
label
Pro-inflammatory cytokines and ...... in major depressive disorder.
@en
Pro-inflammatory cytokines and ...... in major depressive disorder.
@nl
prefLabel
Pro-inflammatory cytokines and ...... in major depressive disorder.
@en
Pro-inflammatory cytokines and ...... in major depressive disorder.
@nl
P50
P1476
Pro-inflammatory cytokines and ...... in major depressive disorder.
@en
P2093
Triin Eller
P304
P356
10.1016/J.PNPBP.2007.09.015
P577
2007-09-26T00:00:00Z